$20,000 of ARDELYX INC lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"The Kidney Patient Act"
You can find more data on corporate lobbying on Quiver Quantitative.
ARDX Insider Trading Activity
ARDX insiders have traded $ARDX stock on the open market 48 times in the past 6 months. Of those trades, 1 have been purchases and 47 have been sales.
Here’s a breakdown of recent trading of $ARDX stock by insiders over the last 6 months:
- DAVID M MOTT purchased 333,333 shares for an estimated $1,946,331
- MICHAEL RAAB (President & CEO) has made 0 purchases and 12 sales selling 225,730 shares for an estimated $1,377,878.
- LAURA A WILLIAMS (Chief Patient Officer) has made 0 purchases and 7 sales selling 97,063 shares for an estimated $582,094.
- ERIC DUANE FOSTER (Chief Commercial Officer) has made 0 purchases and 7 sales selling 18,437 shares for an estimated $111,161.
- MIKE KELLIHER (Chief Business Officer) has made 0 purchases and 6 sales selling 16,843 shares for an estimated $101,525.
- JOSEPH JAMES REILLY (See Remarks) has made 0 purchases and 5 sales selling 8,710 shares for an estimated $52,489.
- JOHN E BISHOP (See Remarks) has made 0 purchases and 4 sales selling 5,485 shares for an estimated $33,039.
- JAMES PARKER BRADY (Chief Human Resources Officer) has made 0 purchases and 3 sales selling 4,389 shares for an estimated $26,437.
- SUSAN HOHENLEITNER (Chief Financial Officer) has made 0 purchases and 3 sales selling 3,488 shares for an estimated $21,005.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ARDX Hedge Fund Activity
We have seen 137 institutional investors add shares of ARDX stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 5,932,859 shares (+49.8%) to their portfolio in Q1 2026, for an estimated $35,537,825
- MARSHALL WACE, LLP removed 3,587,782 shares (-69.1%) from their portfolio in Q1 2026, for an estimated $21,490,814
- CITADEL ADVISORS LLC added 2,137,321 shares (+161.0%) to their portfolio in Q1 2026, for an estimated $12,802,552
- POINT72 ASSET MANAGEMENT, L.P. added 2,025,571 shares (+211.3%) to their portfolio in Q1 2026, for an estimated $12,133,170
- RUBRIC CAPITAL MANAGEMENT LP added 1,860,896 shares (+inf%) to their portfolio in Q1 2026, for an estimated $11,146,767
- STATE STREET CORP added 1,691,968 shares (+14.2%) to their portfolio in Q1 2026, for an estimated $10,134,888
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,424,878 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,535,019
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ARDX Analyst Ratings
Wall Street analysts have issued reports on $ARDX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/20/2026
- Wedbush issued a "Outperform" rating on 01/21/2026
To track analyst ratings and price targets for ARDX, check out Quiver Quantitative's $ARDX forecast page.
ARDX Price Targets
Multiple analysts have issued price targets for $ARDX recently. We have seen 4 analysts offer price targets for $ARDX in the last 6 months, with a median target of $17.5.
Here are some recent targets:
- Caroline Palomeque from Ladenburg Thalmann set a target price of $16.0 on 06/16/2026
- Laura Chico from Wedbush set a target price of $19.0 on 02/23/2026
- Julian Harrison from BTIG set a target price of $17.0 on 02/20/2026
- Matthew Caufield from HC Wainwright & Co. set a target price of $18.0 on 02/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
